The European Association of Pharma Biotechnology (EAPB) represents a central network to promote and develop pharmaceutical biotechnology in Europe.
As a non-profit organization EAPB is linking academia, industry and regulatory bodies.
EAPB is dedicated to the advancement of biotechnology in pharmaceutical sciences, specifically as applied to medicinal drugs, processes, technologies, and associated issues.
Its members constitute professionals from biotechnology and pharmaceutical companies, governmental authorities, academia and scientific organisations.
Dissolution of EAPB
For formal reasons the member’s General Meeting of 17 October 2016 has to be repeated. The General Meeting will take place on 23 May 2017 in Berlin.
More information can be found here.